| Code | Description | Claims | Beneficiaries | Total Paid |
| J0178 |
Injection, aflibercept, 1 mg |
902 |
863 |
$2.12M |
| J2357 |
Injection, omalizumab, 5 mg |
1,231 |
813 |
$2.01M |
| J0585 |
Injection, onabotulinumtoxina, 1 unit |
2,135 |
1,408 |
$1.32M |
| 90378 |
|
2,822 |
689 |
$1.14M |
| J7326 |
Hyaluronan or derivative, gel-one, for intra-articular injection, per dose |
613 |
602 |
$813K |
| J7323 |
Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose |
1,143 |
734 |
$495K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
221 |
215 |
$409K |
| J0897 |
Injection, denosumab, 1 mg |
203 |
189 |
$170K |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
96 |
96 |
$109K |
| Q5104 |
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg |
36 |
26 |
$74K |